Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01690988 · ClinicalTrials.gov registry record · Phase 3
The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial
A Phase 3 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 3
- Development phase
- 746
- Enrollment target
NCT01690988 is a Phase 3 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 746 participants.
The verdict
NCT01690988, a Phase 3 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 746 participants
- Enrollment target
Study Summary
Delirium is a medical term or condition that includes a temporary inability to focus attention and to think clearly. Delirium occurs commonly (10% to 70%) in patients older than 60 undergoing large surgeries. The purpose of this study is to test rigorously whether a drug called ketamine can decrease the chance that patients will experience delirium after their surgery. The investigators are also testing whether ketamine decreases postoperative pain, postoperative opioid consumption, postoperative nausea and vomiting, ICU and hospital length of stay, and adverse outcomes (e.g. hallucinations and nightmares).
Interventions
- DRUG Ketamine (0.5 mg/kg)
- DRUG Normal Saline (placebo)
- DRUG Ketamine (1 mg/kg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 746 participants |
| Start Date | 2014-02-01 |
| Est. Completion | 2017-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01690988
The ClinicalTrials.gov registry entry for NCT01690988 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 746 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ketamine (0.5 mg/kg) is the first listed.
NCT01690988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01690988 about?
NCT01690988 is a clinical study titled "The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial". Delirium is a medical term or condition that includes a temporary inability to focus attention and to think clearly. Delirium occurs commonly (10% to 70%) in patients older than 60 undergoing large surgeries. The purpose of this study is to test rigorously whether a drug called ketamine can decrease...
What is the current status of trial NCT01690988?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 746 participants. The study started on 2014-02-01. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01690988?
The interventions under investigation include: Ketamine (0.5 mg/kg) (DRUG), Normal Saline (placebo) (DRUG), Ketamine (1 mg/kg) (DRUG).
Who is sponsoring clinical trial NCT01690988?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.